PRMT1 Protein Mitigates Brain Damage After Ischemia by Inhibiting RIPK1-Driven Cell Death Pathways
A groundbreaking study recently published in Acta Pharmaceutica Sinica B has shed new light on the molecular mechanisms underlying cerebral ischemia–reperfusion (I/R) injury, a devastating...











